Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
Cash Flows From Operating Activities | |||||
Net Income | -12,155 | -4,076 | -6,391 | -4,006 | -7,242 |
Depreciation Amortization | 23 | 11 | 43 | 26 | 30 |
Accounts payable and accrued liabilities | -515 | 1,102 | 158 | -144 | -83 |
Other Working Capital | 190 | -285 | 627 | -227 | -1,073 |
Other Operating Activity | 2,581 | -1,892 | 579 | 594 | 685 |
Operating Cash Flow | $-9,876 | $-5,140 | $-4,985 | $-3,757 | $-7,683 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -9,979 | -7,504 | 0 | N/A | N/A |
PPE Investments | -9 | -52 | -4 | -3 | -2 |
Other Investing Activity | 2,491 | -6,503 | 0 | 0 | 0 |
Investing Cash Flow | $-7,497 | $-14,060 | $-4 | $-3 | $-2 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | 5,000 | N/A | N/A | N/A |
Common Stock Issued | 18,179 | 9,581 | 5,543 | 1,456 | 3,698 |
Financing Cash Flow | $18,179 | $14,581 | $5,543 | $1,456 | $3,698 |
Beginning Cash Position | 1,410 | 6,029 | 5,475 | 7,779 | 11,767 |
End Cash Position | 2,216 | 1,410 | 6,029 | 5,475 | 7,779 |
Net Cash Flow | $806 | $-4,619 | $554 | $-2,304 | $-3,987 |
Free Cash Flow | |||||
Operating Cash Flow | -9,876 | -5,140 | -4,985 | -3,757 | -7,683 |
Capital Expenditure | -9 | -52 | -4 | -3 | -2 |
Free Cash Flow | -9,885 | -5,193 | -4,989 | -3,760 | -7,686 |